Earnings Beats and FDA Nods Drive Solid Q2 Execution Across Mid-Cap Tech and BiotechGlobal Report·7 hours agoRERE-1.43%REPL+4.82%
Behind the Niche Movers: DexCom's OTC Push and aTyr's Biotech OverhaulGlobal Report·Aug 11 at 04:43 AMATYR-2.18%PCG+2.26%
The Unbundling of Market Exposure: Extreme Financialization and the Limits of Aggregation TheoryGlobal Report·Aug 7 at 04:19 AMANTA0.00%GFUZ-1.53%
Niche Hardware and Healthcare Stocks See Reallocation Squeeze on Strong Mid-2026 DataGlobal Report·Jul 24 at 04:13 AMKSCP+1.40%PKE-2.86%
PRECIOUS METALS | Antalpha Accumulates 15,052 XAUT Over Past 3 Months, Onchain Lens SaysCoinLive·Jul 9 at 03:34 AMANTA0.00%
Antalpha’s XAUT Unrealized Gains Fall by $50 Million, Arkham Data ShowsCoinLive·Jun 25 at 09:09 AMANTA0.00%GLD-1.29%
Antalpha Posts Strong Q1 2026 Results and Launches Web3 AI Agent BetaTip Ranks·May 19 at 05:55 PMANTA0.00%
Antalpha Platform Holding Q1 2026 Earnings Call: Complete Transcriptbenzinga_article·May 19 at 11:05 AMANTA0.00%CANG-3.07%
Antalpha Announces Strategic Expansion Into AI Infrastructure | ANTA Stock NewsStockTitan·May 18 at 08:00 AMANTA0.00%
